2359 — WuXi AppTec Co Share Price
Last trade - 00:00- HK$96.65bn
- HK$88.40bn
- CNY40.34bn
- 79
- 67
- 15
- 56
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.09 | ||
| PEG Ratio (f) | 0.66 | ||
| EPS Growth (f) | 14.05% | ||
| Dividend Yield (f) | 3.48% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.62 | ||
| Price to Tang. Book | 1.74 | ||
| Price to Free Cashflow | 11.35 | ||
| Price to Sales | 2.21 | ||
| EV to EBITDA | 5.82 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 20.13% | ||
| Return on Equity | 18.89% | ||
| Operating Margin | 29.4% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 12,872.21 | 16,535.43 | 22,902.39 | 39,354.78 | 40,340.81 | 41,802.39 | 46,837.8 | 33.22% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -29.11 | +45.48 | +53.64 | +79.68 | +17.54 | +14.88 | +12.41 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The Company is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The Company mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment.
Directors
- Ge Li CHM (54)
- Qing Yang CCE (52)
- Minzhang Chen CCE (52)
- Edward Hu VCH (58)
- Bih-Hsin Chu CFO (51)
- Ming Shi CFO (47)
- Zhaohui Zhang VPR (51)
- Ning Zhao VPR (54)
- Shuhui Chen VPR (57)
- Chi Yao SEC (37)
- Xiaomeng Tong NED (47)
- Yibing Wu NED (53)
- Jiangnan Cai NID (63)
- Dai Feng NID (45)
- Yan Liu NID (48)
- Hetong Lou NID (59)
- Xiaotong Zhang NID (53)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 1st, 2000
- Public Since
- May 8th, 2018
- No. of Shareholders
- 204,725
- No. of Employees
- 41,116
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 2,933,336,997
- Address
- 228 Fute Zhong Road, SHANGHAI, 200131
- Web
- http://www.wuxiapptec.com.cn/
- Phone
- +86 2150461000
- Auditors
- Deloitte & Touche LLP
Latest News for 2359
Upcoming Events for 2359
Similar to 2359
Abbisko Cayman
Stock Exchange of Hong Kong Limited
Akeso
Stock Exchange of Hong Kong Limited
Alphamab Oncology
Stock Exchange of Hong Kong Limited
Antengene
Stock Exchange of Hong Kong Limited
Ascentage Pharma International
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:24 UTC, shares in WuXi AppTec Co are trading at HK$32.95. This share price information is delayed by 15 minutes.
Shares in WuXi AppTec Co last closed at HK$32.95 and the price had moved by -58.89% over the past 365 days. In terms of relative price strength the WuXi AppTec Co share price has underperformed the FTSE Developed Asia Pacific Index by -57.09% over the past year.
The overall consensus recommendation for WuXi AppTec Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The WuXi AppTec Co dividend yield is 3.23% based on the trailing twelve month period.
Last year, WuXi AppTec Co paid a total dividend of CNY0.98, and it currently has a trailing dividend yield of 3.23%. We do not have any data on when WuXi AppTec Co is to next pay dividends.
We do not have data on when WuXi AppTec Co is to next pay dividends. The historic dividend yield on WuXi AppTec Co shares is currently 3.23%.
To buy shares in WuXi AppTec Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$32.95, shares in WuXi AppTec Co had a market capitalisation of HK$96.65bn.
Here are the trading details for WuXi AppTec Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2359
Based on an overall assessment of its quality, value and momentum WuXi AppTec Co is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in WuXi AppTec Co is HK$72.84. That is 121.05% above the last closing price of HK$32.95.
Analysts covering WuXi AppTec Co currently have a consensus Earnings Per Share (EPS) forecast of CNY3.63 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like WuXi AppTec Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -67.2%.
As of the last closing price of HK$32.95, shares in WuXi AppTec Co were trading -54.33% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The WuXi AppTec Co PE ratio based on its reported earnings over the past 12 months is 8.09. The shares last closed at HK$32.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
WuXi AppTec Co's management team is headed by:
- Ge Li - CHM
- Qing Yang - CCE
- Minzhang Chen - CCE
- Edward Hu - VCH
- Bih-Hsin Chu - CFO
- Ming Shi - CFO
- Zhaohui Zhang - VPR
- Ning Zhao - VPR
- Shuhui Chen - VPR
- Chi Yao - SEC
- Xiaomeng Tong - NED
- Yibing Wu - NED
- Jiangnan Cai - NID
- Dai Feng - NID
- Yan Liu - NID
- Hetong Lou - NID
- Xiaotong Zhang - NID